isoflurophate has been researched along with Substance Withdrawal Syndrome in 4 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, LC | 3 |
| Buccafusco, JJ | 3 |
| Shuster, LC | 1 |
| Jonnala, RR | 1 |
| Gattu, M | 1 |
| Russell, RW | 1 |
| Vasquez, BJ | 1 |
| Overstreet, DH | 1 |
| Dalglish, FW | 1 |
4 other studies available for isoflurophate and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Disease Models, Animal; Infusions, Intraveno | 1998 |
Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
Topics: Acetylcholinesterase; Animals; Arecoline; Blood Pressure; Brain; Cardiovascular System; Cholinergic | 2000 |
Adaptive changes in M1 muscarinic receptors localized to specific rostral brain regions during and after morphine withdrawal.
Topics: Animals; Autoradiography; Binding, Competitive; Blood Pressure; Body Weight; Brain; Isoflurophate; M | 2000 |
Consummatory behavior during tolerance to and withdrawal from chronic depression of cholinesterase activity.
Topics: Analysis of Variance; Animals; Cholinesterases; Consummatory Behavior; Depression, Chemical; Drinkin | 1971 |